Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis
Geert‐Jan Geersing(University Medical Center Utrecht), Karel G.M. Moons(Utrecht University), David R. Anderson(Dalhousie University), R. A. Kraaijenhagen(Academic Medical Center), Arno W. Hoes(University Medical Center Utrecht), Shannon M. Bates(Thrombosis and Atherosclerosis Research Institute), Arina J. ten Cate‐Hoek, Scott M. Stevens(Intermountain Medical Center), Roger E. G. Schutgens(Utrecht University), Ruud Oudega(Utrecht University), Nicolaas P. A. Zuithoff(Utrecht University), Johan Elf(Skåne University Hospital), Clive Kearon(McMaster University), P. S. Wells(University of Ottawa), Scott C. Woller(Intermountain Medical Center)
Cited by 227
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
|Journal of Thrombosis and Haemostasis|2005|4.9k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k